Filing metadata

Accession number
0001062993-22-000729
Form type
Form 3
Filer
Avalo Therapeutics, Inc.
CIK
CIK 1534120
Filed
Jan 06, 2022
Reporting period
Jan 03, 2022
Description
Initial ownership

Explore SEC Filings Hub